NCT06816641 Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
| NCT ID | NCT06816641 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Intracerebral Haemorrhage (ICH) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2022-01-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess the safety and efficacy of surgical evacuation of spontaneous intracerebral hemorrhage.
Eligibility Criteria
Inclusion Criteria: * • Patients with radiological findings of ICH. * Age group 20-70 years. Exclusion Criteria: * • Traumatic ICH or ruptured aneurysm or AVM or brain tumor. * Postoperative cranial surgery ICH. * Secondary hydrocephalus. * Patients with other comorbidities e.g., Liver cell failure and renal cell failure. * Patients with bleeding disorders. * Patients who are regular on anticoagulant or antiplatelet therapy. * Small sized ICH\< 30 ml. * GCS less than 6 preoperatively.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06816641 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Intracerebral Haemorrhage (ICH). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06816641 currently recruiting?
Yes, NCT06816641 is actively recruiting participants. Contact the research team at raghibov@gmail.com for enrollment information.
Where is the NCT06816641 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06816641 clinical trial?
NCT06816641 is sponsored by Sohag University. The trial plans to enroll 40 participants.